Serum levels of osteopontin are increased in SIRS and sepsis

Objective In sepsis, dysregulation of the immune response leads to rapid multiorgan failure and death. Accurate and timely diagnosis is lifesaving and should discriminate sepsis from the systemic inflammatory response syndrome (SIRS) caused by non-infectious agents. Osteopontin acts as an extracellu...

Full description

Saved in:
Bibliographic Details
Published inIntensive care medicine Vol. 34; no. 12; pp. 2176 - 2184
Main Authors Vaschetto, Rosanna, Nicola, Stefania, Olivieri, Carlo, Boggio, Elena, Piccolella, Fabio, Mesturini, Riccardo, Damnotti, Federica, Colombo, Davide, Navalesi, Paolo, Della Corte, Francesco, Dianzani, Umberto, Chiocchetti, Annalisa
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer-Verlag 01.12.2008
Springer
Springer Nature B.V
Subjects
Online AccessGet full text
ISSN0342-4642
1432-1238
DOI10.1007/s00134-008-1268-4

Cover

Loading…
Abstract Objective In sepsis, dysregulation of the immune response leads to rapid multiorgan failure and death. Accurate and timely diagnosis is lifesaving and should discriminate sepsis from the systemic inflammatory response syndrome (SIRS) caused by non-infectious agents. Osteopontin acts as an extracellular matrix component or a soluble cytokine in inflamed tissues. Its exact role in immune response and sepsis remains to be elucidated. Therefore, we investigated the role of osteopontin in SIRS and sepsis. Design Prospective, observational study. Setting Intensive care unit of a university hospital. Patients and participants Fifty-six patients with SIRS or sepsis and 56 healthy subjects were enrolled. Interventions We analyzed the serum levels of osteopontin and TH1–TH2 cytokines and investigated the role of osteopontin on interleukin 6 secretion by monocytes. Measurements and main results Serum osteopontin levels were strikingly higher in patients than in controls and in sepsis than in SIRS, and decreased during the resolution of both the disorders. Receiver operating characteristic curves showed that osteopontin levels have discriminative power between SIRS and sepsis with an area under the curve of 0.796. Osteopontin levels directly correlated with those of interleukin 6 and in vitro, recombinant osteopontin increased interleukin 6 secretion by monocytes in both the absence and presence of high doses of lipopolysaccharide. Conclusion These data suggest that osteopontin might be a mediator involved in the pathogenesis of SIRS and sepsis, possibly by supporting interleukin 6 secretion. Descriptor 45. SIRS/Sepsis: clinical studies.
AbstractList In sepsis, dysregulation of the immune response leads to rapid multiorgan failure and death. Accurate and timely diagnosis is lifesaving and should discriminate sepsis from the systemic inflammatory response syndrome (SIRS) caused by non-infectious agents. Osteopontin acts as an extracellular matrix component or a soluble cytokine in inflamed tissues. Its exact role in immune response and sepsis remains to be elucidated. Therefore, we investigated the role of osteopontin in SIRS and sepsis. Prospective, observational study. Intensive care unit of a university hospital. Fifty-six patients with SIRS or sepsis and 56 healthy subjects were enrolled. We analyzed the serum levels of osteopontin and TH1-TH2 cytokines and investigated the role of osteopontin on interleukin 6 secretion by monocytes. Serum osteopontin levels were strikingly higher in patients than in controls and in sepsis than in SIRS, and decreased during the resolution of both the disorders. Receiver operating characteristic curves showed that osteopontin levels have discriminative power between SIRS and sepsis with an area under the curve of 0.796. Osteopontin levels directly correlated with those of interleukin 6 and in vitro, recombinant osteopontin increased interleukin 6 secretion by monocytes in both the absence and presence of high doses of lipopolysaccharide. These data suggest that osteopontin might be a mediator involved in the pathogenesis of SIRS and sepsis, possibly by supporting interleukin 6 secretion. 45. SIRS/Sepsis: clinical studies. [PUBLICATION ABSTRACT]
Objective In sepsis, dysregulation of the immune response leads to rapid multiorgan failure and death. Accurate and timely diagnosis is lifesaving and should discriminate sepsis from the systemic inflammatory response syndrome (SIRS) caused by non-infectious agents. Osteopontin acts as an extracellular matrix component or a soluble cytokine in inflamed tissues. Its exact role in immune response and sepsis remains to be elucidated. Therefore, we investigated the role of osteopontin in SIRS and sepsis. Design Prospective, observational study. Setting Intensive care unit of a university hospital. Patients and participants Fifty-six patients with SIRS or sepsis and 56 healthy subjects were enrolled. Interventions We analyzed the serum levels of osteopontin and TH1–TH2 cytokines and investigated the role of osteopontin on interleukin 6 secretion by monocytes. Measurements and main results Serum osteopontin levels were strikingly higher in patients than in controls and in sepsis than in SIRS, and decreased during the resolution of both the disorders. Receiver operating characteristic curves showed that osteopontin levels have discriminative power between SIRS and sepsis with an area under the curve of 0.796. Osteopontin levels directly correlated with those of interleukin 6 and in vitro, recombinant osteopontin increased interleukin 6 secretion by monocytes in both the absence and presence of high doses of lipopolysaccharide. Conclusion These data suggest that osteopontin might be a mediator involved in the pathogenesis of SIRS and sepsis, possibly by supporting interleukin 6 secretion. Descriptor 45. SIRS/Sepsis: clinical studies.
In sepsis, dysregulation of the immune response leads to rapid multiorgan failure and death. Accurate and timely diagnosis is lifesaving and should discriminate sepsis from the systemic inflammatory response syndrome (SIRS) caused by non-infectious agents. Osteopontin acts as an extracellular matrix component or a soluble cytokine in inflamed tissues. Its exact role in immune response and sepsis remains to be elucidated. Therefore, we investigated the role of osteopontin in SIRS and sepsis.OBJECTIVEIn sepsis, dysregulation of the immune response leads to rapid multiorgan failure and death. Accurate and timely diagnosis is lifesaving and should discriminate sepsis from the systemic inflammatory response syndrome (SIRS) caused by non-infectious agents. Osteopontin acts as an extracellular matrix component or a soluble cytokine in inflamed tissues. Its exact role in immune response and sepsis remains to be elucidated. Therefore, we investigated the role of osteopontin in SIRS and sepsis.Prospective, observational study.DESIGNProspective, observational study.Intensive care unit of a university hospital.SETTINGIntensive care unit of a university hospital.Fifty-six patients with SIRS or sepsis and 56 healthy subjects were enrolled.PATIENTS AND PARTICIPANTSFifty-six patients with SIRS or sepsis and 56 healthy subjects were enrolled.We analyzed the serum levels of osteopontin and TH1-TH2 cytokines and investigated the role of osteopontin on interleukin 6 secretion by monocytes.INTERVENTIONSWe analyzed the serum levels of osteopontin and TH1-TH2 cytokines and investigated the role of osteopontin on interleukin 6 secretion by monocytes.Serum osteopontin levels were strikingly higher in patients than in controls and in sepsis than in SIRS, and decreased during the resolution of both the disorders. Receiver operating characteristic curves showed that osteopontin levels have discriminative power between SIRS and sepsis with an area under the curve of 0.796. Osteopontin levels directly correlated with those of interleukin 6 and in vitro, recombinant osteopontin increased interleukin 6 secretion by monocytes in both the absence and presence of high doses of lipopolysaccharide.MEASUREMENTS AND MAIN RESULTSSerum osteopontin levels were strikingly higher in patients than in controls and in sepsis than in SIRS, and decreased during the resolution of both the disorders. Receiver operating characteristic curves showed that osteopontin levels have discriminative power between SIRS and sepsis with an area under the curve of 0.796. Osteopontin levels directly correlated with those of interleukin 6 and in vitro, recombinant osteopontin increased interleukin 6 secretion by monocytes in both the absence and presence of high doses of lipopolysaccharide.These data suggest that osteopontin might be a mediator involved in the pathogenesis of SIRS and sepsis, possibly by supporting interleukin 6 secretion.CONCLUSIONThese data suggest that osteopontin might be a mediator involved in the pathogenesis of SIRS and sepsis, possibly by supporting interleukin 6 secretion.45. SIRS/Sepsis: clinical studies.DESCRIPTOR45. SIRS/Sepsis: clinical studies.
In sepsis, dysregulation of the immune response leads to rapid multiorgan failure and death. Accurate and timely diagnosis is lifesaving and should discriminate sepsis from the systemic inflammatory response syndrome (SIRS) caused by non-infectious agents. Osteopontin acts as an extracellular matrix component or a soluble cytokine in inflamed tissues. Its exact role in immune response and sepsis remains to be elucidated. Therefore, we investigated the role of osteopontin in SIRS and sepsis. Prospective, observational study. Intensive care unit of a university hospital. Fifty-six patients with SIRS or sepsis and 56 healthy subjects were enrolled. We analyzed the serum levels of osteopontin and TH1-TH2 cytokines and investigated the role of osteopontin on interleukin 6 secretion by monocytes. Serum osteopontin levels were strikingly higher in patients than in controls and in sepsis than in SIRS, and decreased during the resolution of both the disorders. Receiver operating characteristic curves showed that osteopontin levels have discriminative power between SIRS and sepsis with an area under the curve of 0.796. Osteopontin levels directly correlated with those of interleukin 6 and in vitro, recombinant osteopontin increased interleukin 6 secretion by monocytes in both the absence and presence of high doses of lipopolysaccharide. These data suggest that osteopontin might be a mediator involved in the pathogenesis of SIRS and sepsis, possibly by supporting interleukin 6 secretion. 45. SIRS/Sepsis: clinical studies.
Author Piccolella, Fabio
Colombo, Davide
Nicola, Stefania
Boggio, Elena
Damnotti, Federica
Della Corte, Francesco
Chiocchetti, Annalisa
Mesturini, Riccardo
Navalesi, Paolo
Olivieri, Carlo
Vaschetto, Rosanna
Dianzani, Umberto
Author_xml – sequence: 1
  givenname: Rosanna
  surname: Vaschetto
  fullname: Vaschetto, Rosanna
  organization: Department of Clinical and Experimental Medicine, SCDU Anaesthesia and Intensive Care 1, Maggiore della Carità Hospital, “A. Avogadro” University of Eastern Piedmont
– sequence: 2
  givenname: Stefania
  surname: Nicola
  fullname: Nicola, Stefania
  organization: Interdisciplinary Research Center of Autoimmune Diseases (IRCAD) and Department of Medical Science, “A. Avogadro” University of Eastern Piedmont
– sequence: 3
  givenname: Carlo
  surname: Olivieri
  fullname: Olivieri, Carlo
  organization: Department of Clinical and Experimental Medicine, SCDU Anaesthesia and Intensive Care 1, Maggiore della Carità Hospital, “A. Avogadro” University of Eastern Piedmont
– sequence: 4
  givenname: Elena
  surname: Boggio
  fullname: Boggio, Elena
  organization: Interdisciplinary Research Center of Autoimmune Diseases (IRCAD) and Department of Medical Science, “A. Avogadro” University of Eastern Piedmont
– sequence: 5
  givenname: Fabio
  surname: Piccolella
  fullname: Piccolella, Fabio
  organization: Department of Clinical and Experimental Medicine, SCDU Anaesthesia and Intensive Care 1, Maggiore della Carità Hospital, “A. Avogadro” University of Eastern Piedmont
– sequence: 6
  givenname: Riccardo
  surname: Mesturini
  fullname: Mesturini, Riccardo
  organization: Interdisciplinary Research Center of Autoimmune Diseases (IRCAD) and Department of Medical Science, “A. Avogadro” University of Eastern Piedmont
– sequence: 7
  givenname: Federica
  surname: Damnotti
  fullname: Damnotti, Federica
  organization: Department of Clinical and Experimental Medicine, SCDU Anaesthesia and Intensive Care 1, Maggiore della Carità Hospital, “A. Avogadro” University of Eastern Piedmont
– sequence: 8
  givenname: Davide
  surname: Colombo
  fullname: Colombo, Davide
  organization: Department of Clinical and Experimental Medicine, SCDU Anaesthesia and Intensive Care 1, Maggiore della Carità Hospital, “A. Avogadro” University of Eastern Piedmont
– sequence: 9
  givenname: Paolo
  surname: Navalesi
  fullname: Navalesi, Paolo
  organization: Department of Clinical and Experimental Medicine, SCDU Anaesthesia and Intensive Care 1, Maggiore della Carità Hospital, “A. Avogadro” University of Eastern Piedmont
– sequence: 10
  givenname: Francesco
  surname: Della Corte
  fullname: Della Corte, Francesco
  organization: Department of Clinical and Experimental Medicine, SCDU Anaesthesia and Intensive Care 1, Maggiore della Carità Hospital, “A. Avogadro” University of Eastern Piedmont
– sequence: 11
  givenname: Umberto
  surname: Dianzani
  fullname: Dianzani, Umberto
  email: dianzani@med.unipmn.it
  organization: Interdisciplinary Research Center of Autoimmune Diseases (IRCAD) and Department of Medical Science, “A. Avogadro” University of Eastern Piedmont
– sequence: 12
  givenname: Annalisa
  surname: Chiocchetti
  fullname: Chiocchetti, Annalisa
  organization: Interdisciplinary Research Center of Autoimmune Diseases (IRCAD) and Department of Medical Science, “A. Avogadro” University of Eastern Piedmont
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20894793$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/18807011$$D View this record in MEDLINE/PubMed
BookMark eNp9kVtr3DAQhUVJaTZJf0Begimkb251syVDX0LoJRAodNNnMZbHQcErbTR2of8-WnbbQKB9kgTfOTM654QdxRSRsXPBPwjOzUfiXChdc25rIVtb61dsJbSS5aXsEVtxpWWtWy2P2QnRQ6FN24g37FhYyw0XYsU-rTEvm2rCXzhRlcYq0Yxpm-IcYgUZqxB9RiAcyq1a3_xYVxCHinBLgc7Y6xEmwreH85T9_PL57vpbffv968311W3tVdfNtWitMShG7oVoeN_1yncKrGoaGKHpkPtxaFU_eBh6MwxlSWkAei9aKdBDq07Z-73vNqfHBWl2m0AepwkipoVc21mhpZUFfPcCfEhLjmU3J4tbScXqAl0coKXf4OC2OWwg_3Z_QinA5QEA8jCNGaIP9JeT3HbadKpwYs_5nIgyjs9W3O0KcvuCXCnI7Qpyu-HmhcaHGeZQAs8Qpv8q5V5JZUq8x_z8t3-LngCvHKHj
CODEN ICMED9
CitedBy_id crossref_primary_10_1007_s11845_011_0741_1
crossref_primary_10_1016_j_talanta_2019_120624
crossref_primary_10_1186_s13054_015_0782_3
crossref_primary_10_32997_rcb_2018_2711
crossref_primary_10_1111_j_1582_4934_2009_00929_x
crossref_primary_10_1183_09031936_00002710
crossref_primary_10_4103_tcmj_tcmj_269_20
crossref_primary_10_3390_biomedicines11061627
crossref_primary_10_1093_ndt_gfq498
crossref_primary_10_3390_cells8070695
crossref_primary_10_1017_S1462399411001839
crossref_primary_10_1186_s13054_015_0988_4
crossref_primary_10_1111_aas_12422
crossref_primary_10_1111_j_1553_2712_2010_00792_x
crossref_primary_10_1186_cc8872
crossref_primary_10_1097_MPA_0000000000000991
crossref_primary_10_1177_0394632017749356
crossref_primary_10_1186_s12950_025_00430_4
crossref_primary_10_3390_ijms25179620
crossref_primary_10_1016_j_urolonc_2009_10_009
crossref_primary_10_1371_journal_pntd_0000806
crossref_primary_10_1007_s11255_020_02417_x
crossref_primary_10_15324_kjcls_2021_53_4_309
crossref_primary_10_3389_fphys_2018_01779
crossref_primary_10_1177_1553350617739424
crossref_primary_10_1007_s11064_020_03119_7
crossref_primary_10_3390_medicina60050724
crossref_primary_10_1007_s11684_014_0318_2
crossref_primary_10_3390_life12030397
crossref_primary_10_1155_2017_4049098
crossref_primary_10_1155_2016_9345495
crossref_primary_10_1189_jlb_0912437
crossref_primary_10_1093_infdis_jir185
crossref_primary_10_3109_00365548_2010_530686
crossref_primary_10_1016_j_ejim_2020_04_035
crossref_primary_10_1016_j_cellimm_2017_05_004
crossref_primary_10_1016_j_joca_2012_07_021
crossref_primary_10_1007_s00134_008_1371_6
crossref_primary_10_1080_0886022X_2020_1721300
crossref_primary_10_1111_crj_12072
crossref_primary_10_3390_genes14071366
crossref_primary_10_3390_ijms19010007
crossref_primary_10_1016_j_bone_2010_04_602
crossref_primary_10_1097_SHK_0000000000000611
crossref_primary_10_1007_s00259_016_3429_y
crossref_primary_10_1016_j_celrep_2021_110170
crossref_primary_10_3390_cells8080815
crossref_primary_10_3390_cells8020174
crossref_primary_10_2106_JBJS_OA_20_00067
crossref_primary_10_1093_infdis_jiae320
crossref_primary_10_1126_sciadv_abm5900
crossref_primary_10_1186_s40064_016_3591_5
Cites_doi 10.1093/rheumatology/keh558
10.1016/j.cyto.2005.01.014
10.1046/j.1365-2796.1998.00379.x
10.1016/S0022-3476(98)70448-2
10.1034/j.1399-6576.2002.460412.x
10.1097/MCG.0b013e31802d6268
10.1016/S0167-5699(00)01715-1
10.1002/ana.10606
10.1080/00365520510024061
10.1016/j.jneuroim.2004.09.004
10.1007/s00134-002-1398-z
10.1097/00003246-200004000-00007
10.1016/S1473-3099(07)70052-X
10.1016/j.jneuroim.2005.02.020
10.1046/j.1523-1755.2003.00767.x
10.1002/art.20808
10.1007/s00134-001-1143-z
10.1016/S0009-8981(02)00101-8
10.1126/science.287.5454.860
10.1507/endocrj.51.499
10.1097/00003246-199609000-00002
10.1001/jama.271.23.1836
10.1517/14728222.11.1.81
10.1097/00003246-198510000-00009
10.1002/(SICI)1097-0258(19980515)17:9<1033::AID-SIM784>3.0.CO;2-Z
10.1001/jama.1994.03510470040032
10.4049/jimmunol.168.5.2096
10.1128/IAI.67.8.4223-4230.1999
10.1172/JCI200319190
10.1164/ajrccm.164.12.2104139
10.1002/jlb.60.3.397
10.1111/j.1651-2227.2003.tb00534.x
10.1111/j.1742-1241.2007.01368.x
10.1002/j.1460-2075.1990.tb08316.x
10.1164/ajrccm.164.3.2009052
10.1177/0310057X0203000605
10.1016/S0002-9440(10)64514-2
10.1097/00003246-199206000-00025
ContentType Journal Article
Copyright Springer-Verlag 2008
2009 INIST-CNRS
Copyright_xml – notice: Springer-Verlag 2008
– notice: 2009 INIST-CNRS
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7RV
7X7
7XB
88E
8AO
8FD
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FR3
FYUFA
GHDGH
K9.
M0S
M1P
M7Z
NAPCQ
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
DOI 10.1007/s00134-008-1268-4
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Nursing & Allied Health Database
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Technology Research Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni Edition)
ProQuest Central UK/Ireland
ProQuest Central
ProQuest One Community College
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
Medical Database
Biochemistry Abstracts 1
Nursing & Allied Health Premium
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Biochemistry Abstracts 1
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Technology Research Database

MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1432-1238
EndPage 2184
ExternalDocumentID 1598623981
18807011
20894793
10_1007_s00134_008_1268_4
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Italy
GeographicLocations_xml – name: Italy
GrantInformation_xml – fundername: Telethon
  grantid: GGP04071
GroupedDBID ---
-53
-5E
-5G
-BR
-EM
-Y2
-~C
.55
.86
.GJ
.VR
06C
06D
0R~
0VY
199
1N0
1SB
2.D
203
28-
29J
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
36B
3V.
4.4
406
408
409
40D
40E
53G
5GY
5QI
5RE
5VS
67Z
6NX
78A
7RV
7X7
88E
8AO
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AAQQT
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAWTL
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHFT
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABLJU
ABMNI
ABMQK
ABNWP
ABOCM
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABUWZ
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFO
ACGFS
ACHSB
ACHVE
ACHXU
ACIHN
ACIWK
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACREN
ACUDM
ACZOJ
ADBBV
ADHHG
ADHIR
ADIMF
ADINQ
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADYOE
ADZKW
AEAQA
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFEXP
AFFNX
AFJLC
AFKRA
AFLOW
AFQWF
AFRAH
AFWTZ
AFYQB
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMTXH
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
AXYYD
AZFZN
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BKEYQ
BPHCQ
BSONS
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
EIOEI
EJD
EMB
EMOBN
EN4
ESBYG
EX3
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GRRUI
GXS
H13
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IAO
IEA
IHE
IHR
IJ-
IKXTQ
IMOTQ
INH
IOF
ITC
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
J5H
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
LAS
LLZTM
LMP
M1P
M4Y
MA-
MJL
N2Q
N9A
NAPCQ
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
OVD
P19
P2P
P9S
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RIG
RNI
ROL
RPX
RRX
RSV
RZK
S16
S1Z
S26
S27
S28
S37
S3B
SAP
SCLPG
SDE
SDH
SDM
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
T16
TEORI
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
WOW
X7M
YCJ
YLTOR
Z45
Z5O
Z7U
Z7X
Z82
Z83
Z86
Z87
Z8O
Z8V
Z8W
Z8Z
Z91
ZGI
ZMTXR
ZOVNA
~EX
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACMFV
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
ABRTQ
IQODW
PJZUB
PPXIY
CGR
CUY
CVF
ECM
EIF
NPM
7XB
8FD
8FK
FR3
K9.
M7Z
P64
PKEHL
PQEST
PQUKI
PRINS
7X8
PUEGO
ID FETCH-LOGICAL-c399t-16877e1f0c1150b9b3c93a8355afa59e0cfd63bdcadb7dd17627aabc1621eca63
IEDL.DBID U2A
ISSN 0342-4642
IngestDate Sun Aug 24 03:46:51 EDT 2025
Sat Aug 16 23:11:49 EDT 2025
Mon Jul 21 05:47:07 EDT 2025
Mon Jul 21 09:15:33 EDT 2025
Thu Apr 24 23:11:55 EDT 2025
Tue Jul 01 03:51:00 EDT 2025
Fri Feb 21 02:35:16 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords Sepsis
Inflammation
Immunity
Cytokine
Infection
Sepsis syndrome
Intensive care
Immunity Inflammation
Cytokine, Sepsis
Osteopontin
Resuscitation
Language English
License http://www.springer.com/tdm
CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c399t-16877e1f0c1150b9b3c93a8355afa59e0cfd63bdcadb7dd17627aabc1621eca63
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 18807011
PQID 216223884
PQPubID 48752
PageCount 9
ParticipantIDs proquest_miscellaneous_69814282
proquest_journals_216223884
pubmed_primary_18807011
pascalfrancis_primary_20894793
crossref_primary_10_1007_s00134_008_1268_4
crossref_citationtrail_10_1007_s00134_008_1268_4
springer_journals_10_1007_s00134_008_1268_4
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2008-12-01
PublicationDateYYYYMMDD 2008-12-01
PublicationDate_xml – month: 12
  year: 2008
  text: 2008-12-01
  day: 01
PublicationDecade 2000
PublicationPlace Berlin/Heidelberg
PublicationPlace_xml – name: Berlin/Heidelberg
– name: Heidelberg
– name: United States
PublicationTitle Intensive care medicine
PublicationTitleAbbrev Intensive Care Med
PublicationTitleAlternate Intensive Care Med
PublicationYear 2008
Publisher Springer-Verlag
Springer
Springer Nature B.V
Publisher_xml – name: Springer-Verlag
– name: Springer
– name: Springer Nature B.V
References O’Regan, Nau, Chupp, Berman (CR23) 2000; 21
Meisner (CR30) 2002; 323
Chiocchetti, Comi, Indelicato, Castelli, Mesturini, Bensi, Mazzarino, Giordano, D’Alfonso, Momigliano-Richiardi, Liguori, Zorzon, Amoroso, Trojano, Monaco, Leone, Magnani, Dianzani (CR11) 2005; 163
Vincent, Moreno, Takala, Willatts, de, Bruining, Reinhart, Suter, Thijs (CR17) 1996; 22
Akira, Isshiki, Sugita, Tanabe, Kinoshita, Nishio, Nakajima, Hirano, Kishimoto (CR37) 1990; 9
Cohen, Carlet (CR3) 1996; 24
Tang, Eslick, Craig, McLean (CR29) 2007; 7
Resch, Gusenleitner, Muller (CR36) 2003; 92
Rollo, Laskin, Denhardt (CR7) 1996; 60
Oberholzer, Souza, Tschoeke, Oberholzer, Abouhamze, Pribble, Moldawer (CR20) 2005; 23
Tugrul, Esen, Celebi, Ozcan, Akinci, Cakar, Telci (CR33) 2002; 30
Persy, Verhulst, Ysebaert, De Greef, De Broe (CR39) 2003; 63
Inomata, Shijubo, Kon, Maeda, Yamada, Sato, Abe, Uede (CR13) 2005; 30
D’Alfonso, Barizzone, Giordano, Chiocchetti, Magnani, Castelli, Indelicato, Giacopelli, Marchini, Scorza, Danieli, Cappelli, Migliaresi, Bigliardo, Sabbadini, Baldissera, Galeazzi, Sebastiani, Minisola, Ravazzolo, Dianzani, Momigliano-Richiardi (CR28) 2005; 52
Arai, Yokosuka, Kanda, Fukai, Imazeki, Muramatsu, Seki, Miyazaki, Ochiai, Hirasawa, Saisho (CR14) 2006; 41
Giamarellos-Bourboulis, Mega, Grecka, Scarpa, Koratzanis, Thomopoulos, Giamarellou (CR31) 2002; 28
Takahashi, Takahashi, Shimizu, Cui, Tada, Takahashi, Soma, Yoshioka, Fukuchi (CR8) 2004; 182
Mishima, Takeshima, Sawai, Ohba, Ohnita, Isomoto, Omagari, Mizuta, Ozono, Kohno (CR9) 2007; 41
Metz, Herman, Shen (CR18) 1998; 17
Wanner, Keel, Steckholzer, Beier, Stocker, Ertel (CR34) 2000; 28
Nau, Chupp, Emile, Jouanguy, Berman, Casanova, Young (CR25) 2000; 157
(CR15) 1992; 20
Ruokonen, Ilkka, Niskanen, Takala (CR32) 2002; 46
Zhao, Li, Wang, Pan, Ning, Hui, Xie, Wang, Han, Liu, Fan (CR27) 2008; 62
Harbarth, Holeckova, Froidevaux, Pittet, Ricou, Grau, Vadas, Pugin (CR19) 2001; 164
Doellner, Arntzen, Haereid, Aag, Austgulen (CR35) 1998; 132
Fisher, Dhainaut, Opal, Pribble, Balk, Slotman, Iberti, Rackow, Shapiro, Greenman (CR4) 1994; 271
Leibovici, Shraga, Drucker, Konigsberger, Samra, Pitlik (CR2) 1998; 244
Alberti, Brun-Buisson, Burchardi, Martin, Goodman, Artigas, Sicignano, Palazzo, Moreno, Boulme, Lepage, Le (CR1) 2002; 28
Gravallese (CR6) 2003; 112
Jain, Chakraborty, Bulbule, Kaur, Kundu (CR21) 2007; 11
Comabella, Pericot, Goertsches, Nos, Castillo, Blas, Rio, Montalban (CR24) 2005; 158
O’Regan, Hayden, Body, Liaw, Mulligan, Goetschkes, Berman (CR38) 2001; 164
Yamaguchi, Igarashi, Hirata, Tsuchiya, Sugiyama, Morita, Jimbu, Ohnuma, Daimon, Tominaga, Kato (CR26) 2004; 51
Vogt, Lopatinskaya, Smits, Polman, Nagelkerken (CR12) 2003; 53
Knaus, Draper, Wagner, Zimmerman (CR16) 1985; 13
Jansson, Panoutsakopoulou, Baker, Klein, Cantor (CR22) 2002; 168
Ashkar, Weber, Panoutsakopoulou, Sanchirico, Jansson, Zawaideh, Rittling, Denhardt, Glimcher, Cantor (CR5) 2000; 287
Nau, Liaw, Chupp, Berman, Hogan, Young (CR40) 1999; 67
Wong, Lit, Tam, Li, Lam (CR10) 2005; 44
S Jain (1268_CR21) 2007; 11
R Mishima (1268_CR9) 2007; 41
S Tugrul (1268_CR33) 2002; 30
S Akira (1268_CR37) 1990; 9
A Oberholzer (1268_CR20) 2005; 23
WA Knaus (1268_CR16) 1985; 13
AW O’Regan (1268_CR38) 2001; 164
H Doellner (1268_CR35) 1998; 132
L Leibovici (1268_CR2) 1998; 244
M Comabella (1268_CR24) 2005; 158
JL Vincent (1268_CR17) 1996; 22
CJ Fisher Jr (1268_CR4) 1994; 271
S D’Alfonso (1268_CR28) 2005; 52
AW O’Regan (1268_CR23) 2000; 21
H Yamaguchi (1268_CR26) 2004; 51
VP Persy (1268_CR39) 2003; 63
CE Metz (1268_CR18) 1998; 17
EJ Giamarellos-Bourboulis (1268_CR31) 2002; 28
1268_CR27
C Alberti (1268_CR1) 2002; 28
1268_CR15
GA Wanner (1268_CR34) 2000; 28
MH Vogt (1268_CR12) 2003; 53
F Takahashi (1268_CR8) 2004; 182
A Chiocchetti (1268_CR11) 2005; 163
M Arai (1268_CR14) 2006; 41
S Ashkar (1268_CR5) 2000; 287
EE Rollo (1268_CR7) 1996; 60
GJ Nau (1268_CR40) 1999; 67
S Harbarth (1268_CR19) 2001; 164
GJ Nau (1268_CR25) 2000; 157
M Meisner (1268_CR30) 2002; 323
E Ruokonen (1268_CR32) 2002; 46
CK Wong (1268_CR10) 2005; 44
S Inomata (1268_CR13) 2005; 30
BM Tang (1268_CR29) 2007; 7
B Resch (1268_CR36) 2003; 92
EM Gravallese (1268_CR6) 2003; 112
J Cohen (1268_CR3) 1996; 24
M Jansson (1268_CR22) 2002; 168
18807010 - Intensive Care Med. 2008 Dec;34(12):2134-5. doi: 10.1007/s00134-008-1275-5.
References_xml – volume: 60
  start-page: 397
  year: 1996
  end-page: 404
  ident: CR7
  article-title: Osteopontin inhibits nitric oxide production and cytotoxicity by activated RAW264.7 macrophages
  publication-title: J Leukoc Biol
– volume: 44
  start-page: 602
  year: 2005
  end-page: 606
  ident: CR10
  article-title: Elevation of plasma osteopontin concentration is correlated with disease activity in patients with systemic lupus erythematosus
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/keh558
– volume: 30
  start-page: 203
  year: 2005
  end-page: 211
  ident: CR13
  article-title: Circulating interleukin 18 and osteopontin are useful to evaluate disease activity in patients with tuberculosis
  publication-title: Cytokine
  doi: 10.1016/j.cyto.2005.01.014
– volume: 244
  start-page: 379
  year: 1998
  end-page: 386
  ident: CR2
  article-title: The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection
  publication-title: J Intern Med
  doi: 10.1046/j.1365-2796.1998.00379.x
– volume: 132
  start-page: 295
  year: 1998
  end-page: 299
  ident: CR35
  article-title: Interleukin 6 concentrations in neonates evaluated for sepsis
  publication-title: J Pediatr
  doi: 10.1016/S0022-3476(98)70448-2
– volume: 30
  start-page: 747
  year: 2002
  end-page: 754
  ident: CR33
  article-title: Reliability of procalcitonin as a severity marker in critically ill patients with inflammatory response
  publication-title: Anaesth Intensive Care
– volume: 46
  start-page: 398
  year: 2002
  end-page: 404
  ident: CR32
  article-title: Procalcitonin and neopterin as indicators of infection in critically ill patients
  publication-title: Acta Anaesthesiol Scand
  doi: 10.1034/j.1399-6576.2002.460412.x
– volume: 67
  start-page: 4223
  year: 1999
  end-page: 4230
  ident: CR40
  article-title: Attenuated host resistance against Mycobacterium bovis BCG infection in mice lacking osteopontin
  publication-title: Infect Immun
– volume: 20
  start-page: 864
  year: 1992
  end-page: 874
  ident: CR15
  article-title: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis
  publication-title: Crit Care Med
– volume: 41
  start-page: 167
  year: 2007
  end-page: 172
  ident: CR9
  article-title: High plasma osteopontin levels in patients with inflammatory bowel disease
  publication-title: J Clin Gastroenterol
  doi: 10.1097/MCG.0b013e31802d6268
– volume: 157
  start-page: 37
  year: 2000
  end-page: 42
  ident: CR25
  article-title: Osteopontin expression correlates with clinical outcome in patients with mycobacterial infection
  publication-title: Am J Pathol
– volume: 21
  start-page: 475
  year: 2000
  end-page: 478
  ident: CR23
  article-title: Osteopontin (Eta-1) in cell-mediated immunity: teaching an old dog new tricks
  publication-title: Immunol Today
  doi: 10.1016/S0167-5699(00)01715-1
– volume: 53
  start-page: 819
  year: 2003
  end-page: 822
  ident: CR12
  article-title: Elevated osteopontin levels in active relapsing-remitting multiple sclerosis
  publication-title: Ann Neurol
  doi: 10.1002/ana.10606
– volume: 41
  start-page: 102
  year: 2006
  end-page: 110
  ident: CR14
  article-title: Serum osteopontin levels in patients with acute liver dysfunction
  publication-title: Scand J Gastroenterol
  doi: 10.1080/00365520510024061
– volume: 158
  start-page: 231
  year: 2005
  end-page: 239
  ident: CR24
  article-title: Plasma osteopontin levels in multiple sclerosis
  publication-title: J Neuroimmunol
  doi: 10.1016/j.jneuroim.2004.09.004
– volume: 28
  start-page: 1351
  year: 2002
  end-page: 1356
  ident: CR31
  article-title: Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient?
  publication-title: Intensive Care Med
  doi: 10.1007/s00134-002-1398-z
– volume: 28
  start-page: 950
  year: 2000
  end-page: 957
  ident: CR34
  article-title: Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients
  publication-title: Crit Care Med
  doi: 10.1097/00003246-200004000-00007
– volume: 7
  start-page: 210
  year: 2007
  end-page: 217
  ident: CR29
  article-title: Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis
  publication-title: Lancet Infect Dis
  doi: 10.1016/S1473-3099(07)70052-X
– volume: 163
  start-page: 172
  year: 2005
  end-page: 178
  ident: CR11
  article-title: Osteopontin gene haplotypes correlate with multiple sclerosis development and progression
  publication-title: J Neuroimmunol
  doi: 10.1016/j.jneuroim.2005.02.020
– volume: 63
  start-page: 543
  year: 2003
  end-page: 553
  ident: CR39
  article-title: Reduced postischemic macrophage infiltration and interstitial fibrosis in osteopontin knockout mice
  publication-title: Kidney Int
  doi: 10.1046/j.1523-1755.2003.00767.x
– volume: 52
  start-page: 539
  year: 2005
  end-page: 547
  ident: CR28
  article-title: Two single-nucleotide polymorphisms in the 5′ and 3′ ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus
  publication-title: Arthritis Rheum
  doi: 10.1002/art.20808
– volume: 92
  start-page: 243
  year: 2003
  end-page: 245
  ident: CR36
  article-title: Procalcitonin and interleukin 6 in the diagnosis of early-onset sepsis of the neonate
  publication-title: Acta Paediatr
– volume: 28
  start-page: 108
  year: 2002
  end-page: 121
  ident: CR1
  article-title: Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study
  publication-title: Intensive Care Med
  doi: 10.1007/s00134-001-1143-z
– volume: 22
  start-page: 707
  year: 1996
  end-page: 710
  ident: CR17
  article-title: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure
  publication-title: On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med
– volume: 323
  start-page: 17
  year: 2002
  end-page: 29
  ident: CR30
  article-title: Pathobiochemistry and clinical use of procalcitonin
  publication-title: Clin Chim Acta
  doi: 10.1016/S0009-8981(02)00101-8
– volume: 287
  start-page: 860
  year: 2000
  end-page: 864
  ident: CR5
  article-title: Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity
  publication-title: Science
  doi: 10.1126/science.287.5454.860
– volume: 112
  start-page: 147
  year: 2003
  end-page: 149
  ident: CR6
  article-title: Osteopontin: a bridge between bone and the immune system
  publication-title: J Clin Invest
– volume: 51
  start-page: 499
  year: 2004
  end-page: 504
  ident: CR26
  article-title: Progression of diabetic nephropathy enhances the plasma osteopontin level in type 2 diabetic patients
  publication-title: Endocr J
  doi: 10.1507/endocrj.51.499
– volume: 24
  start-page: 1431
  year: 1996
  end-page: 1440
  ident: CR3
  article-title: INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group
  publication-title: Crit Care Med
  doi: 10.1097/00003246-199609000-00002
– volume: 271
  start-page: 1836
  year: 1994
  end-page: 1843
  ident: CR4
  article-title: Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group
  publication-title: JAMA
  doi: 10.1001/jama.271.23.1836
– volume: 9
  start-page: 1897
  year: 1990
  end-page: 1906
  ident: CR37
  article-title: A nuclear factor for IL6 expression (NF-IL6) is a member of a C/EBP family
  publication-title: EMBO J
– volume: 164
  start-page: 2243
  year: 2001
  end-page: 2247
  ident: CR38
  article-title: Abnormal pulmonary granuloma formation in osteopontin-deficient mice
  publication-title: Am J Respir Crit Care Med
– volume: 11
  start-page: 81
  year: 2007
  end-page: 90
  ident: CR21
  article-title: Osteopontin: an emerging therapeutic target for anticancer therapy
  publication-title: Expert Opin Ther Targets
  doi: 10.1517/14728222.11.1.81
– volume: 13
  start-page: 818
  year: 1985
  end-page: 829
  ident: CR16
  article-title: APACHE II: a severity of disease classification system
  publication-title: Crit Care Med
  doi: 10.1097/00003246-198510000-00009
– volume: 23
  start-page: 488
  year: 2005
  end-page: 493
  ident: CR20
  article-title: Plasma cytokine measurements augment prognostic scores as indicators of outcome in patients with severe sepsis
  publication-title: Shock
– volume: 182
  start-page: 173
  year: 2004
  end-page: 185
  ident: CR8
  article-title: Osteopontin is strongly expressed by alveolar macrophages in the lungs of acute respiratory distress syndrome
  publication-title: Lung
– volume: 62
  start-page: 1056
  issue: 7
  year: 2008
  end-page: 1062
  ident: CR27
  article-title: Elevated plasma osteopontin level is predictive of cirrhosis in patients with hepatitis B infection
  publication-title: Int J Clin Pract
– volume: 17
  start-page: 1033
  year: 1998
  end-page: 1053
  ident: CR18
  article-title: Maximum likelihood estimation of receiver operating characteristic (ROC) curves from continuously-distributed data
  publication-title: Stat Med
  doi: 10.1002/(SICI)1097-0258(19980515)17:9<1033::AID-SIM784>3.0.CO;2-Z
– volume: 164
  start-page: 396
  year: 2001
  end-page: 402
  ident: CR19
  article-title: Diagnostic value of procalcitonin, interleukin 6, and interleukin 8 in critically ill patients admitted with suspected sepsis
  publication-title: Am J Respir Crit Care Med
– volume: 168
  start-page: 2096
  year: 2002
  end-page: 2099
  ident: CR22
  article-title: Cutting edge: attenuated experimental autoimmune encephalomyelitis in eta-1/osteopontin-deficient mice
  publication-title: J Immunol
– volume: 44
  start-page: 602
  year: 2005
  ident: 1268_CR10
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/keh558
– volume: 30
  start-page: 203
  year: 2005
  ident: 1268_CR13
  publication-title: Cytokine
  doi: 10.1016/j.cyto.2005.01.014
– volume: 182
  start-page: 173
  year: 2004
  ident: 1268_CR8
  publication-title: Lung
– volume: 51
  start-page: 499
  year: 2004
  ident: 1268_CR26
  publication-title: Endocr J
  doi: 10.1507/endocrj.51.499
– volume: 323
  start-page: 17
  year: 2002
  ident: 1268_CR30
  publication-title: Clin Chim Acta
  doi: 10.1016/S0009-8981(02)00101-8
– volume: 23
  start-page: 488
  year: 2005
  ident: 1268_CR20
  publication-title: Shock
– volume: 271
  start-page: 1836
  year: 1994
  ident: 1268_CR4
  publication-title: JAMA
  doi: 10.1001/jama.1994.03510470040032
– volume: 28
  start-page: 950
  year: 2000
  ident: 1268_CR34
  publication-title: Crit Care Med
  doi: 10.1097/00003246-200004000-00007
– volume: 21
  start-page: 475
  year: 2000
  ident: 1268_CR23
  publication-title: Immunol Today
  doi: 10.1016/S0167-5699(00)01715-1
– volume: 53
  start-page: 819
  year: 2003
  ident: 1268_CR12
  publication-title: Ann Neurol
  doi: 10.1002/ana.10606
– volume: 22
  start-page: 707
  year: 1996
  ident: 1268_CR17
  publication-title: On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med
– volume: 168
  start-page: 2096
  year: 2002
  ident: 1268_CR22
  publication-title: J Immunol
  doi: 10.4049/jimmunol.168.5.2096
– volume: 158
  start-page: 231
  year: 2005
  ident: 1268_CR24
  publication-title: J Neuroimmunol
  doi: 10.1016/j.jneuroim.2004.09.004
– volume: 7
  start-page: 210
  year: 2007
  ident: 1268_CR29
  publication-title: Lancet Infect Dis
  doi: 10.1016/S1473-3099(07)70052-X
– volume: 13
  start-page: 818
  year: 1985
  ident: 1268_CR16
  publication-title: Crit Care Med
  doi: 10.1097/00003246-198510000-00009
– volume: 63
  start-page: 543
  year: 2003
  ident: 1268_CR39
  publication-title: Kidney Int
  doi: 10.1046/j.1523-1755.2003.00767.x
– volume: 244
  start-page: 379
  year: 1998
  ident: 1268_CR2
  publication-title: J Intern Med
  doi: 10.1046/j.1365-2796.1998.00379.x
– volume: 67
  start-page: 4223
  year: 1999
  ident: 1268_CR40
  publication-title: Infect Immun
  doi: 10.1128/IAI.67.8.4223-4230.1999
– volume: 112
  start-page: 147
  year: 2003
  ident: 1268_CR6
  publication-title: J Clin Invest
  doi: 10.1172/JCI200319190
– volume: 164
  start-page: 2243
  year: 2001
  ident: 1268_CR38
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/ajrccm.164.12.2104139
– volume: 41
  start-page: 167
  year: 2007
  ident: 1268_CR9
  publication-title: J Clin Gastroenterol
  doi: 10.1097/MCG.0b013e31802d6268
– volume: 46
  start-page: 398
  year: 2002
  ident: 1268_CR32
  publication-title: Acta Anaesthesiol Scand
  doi: 10.1034/j.1399-6576.2002.460412.x
– volume: 28
  start-page: 108
  year: 2002
  ident: 1268_CR1
  publication-title: Intensive Care Med
  doi: 10.1007/s00134-001-1143-z
– volume: 24
  start-page: 1431
  year: 1996
  ident: 1268_CR3
  publication-title: Crit Care Med
  doi: 10.1097/00003246-199609000-00002
– volume: 60
  start-page: 397
  year: 1996
  ident: 1268_CR7
  publication-title: J Leukoc Biol
  doi: 10.1002/jlb.60.3.397
– volume: 92
  start-page: 243
  year: 2003
  ident: 1268_CR36
  publication-title: Acta Paediatr
  doi: 10.1111/j.1651-2227.2003.tb00534.x
– ident: 1268_CR27
  doi: 10.1111/j.1742-1241.2007.01368.x
– volume: 9
  start-page: 1897
  year: 1990
  ident: 1268_CR37
  publication-title: EMBO J
  doi: 10.1002/j.1460-2075.1990.tb08316.x
– volume: 11
  start-page: 81
  year: 2007
  ident: 1268_CR21
  publication-title: Expert Opin Ther Targets
  doi: 10.1517/14728222.11.1.81
– volume: 28
  start-page: 1351
  year: 2002
  ident: 1268_CR31
  publication-title: Intensive Care Med
  doi: 10.1007/s00134-002-1398-z
– volume: 163
  start-page: 172
  year: 2005
  ident: 1268_CR11
  publication-title: J Neuroimmunol
  doi: 10.1016/j.jneuroim.2005.02.020
– volume: 41
  start-page: 102
  year: 2006
  ident: 1268_CR14
  publication-title: Scand J Gastroenterol
  doi: 10.1080/00365520510024061
– volume: 287
  start-page: 860
  year: 2000
  ident: 1268_CR5
  publication-title: Science
  doi: 10.1126/science.287.5454.860
– volume: 17
  start-page: 1033
  year: 1998
  ident: 1268_CR18
  publication-title: Stat Med
  doi: 10.1002/(SICI)1097-0258(19980515)17:9<1033::AID-SIM784>3.0.CO;2-Z
– volume: 164
  start-page: 396
  year: 2001
  ident: 1268_CR19
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/ajrccm.164.3.2009052
– volume: 30
  start-page: 747
  year: 2002
  ident: 1268_CR33
  publication-title: Anaesth Intensive Care
  doi: 10.1177/0310057X0203000605
– volume: 157
  start-page: 37
  year: 2000
  ident: 1268_CR25
  publication-title: Am J Pathol
  doi: 10.1016/S0002-9440(10)64514-2
– volume: 132
  start-page: 295
  year: 1998
  ident: 1268_CR35
  publication-title: J Pediatr
  doi: 10.1016/S0022-3476(98)70448-2
– volume: 52
  start-page: 539
  year: 2005
  ident: 1268_CR28
  publication-title: Arthritis Rheum
  doi: 10.1002/art.20808
– ident: 1268_CR15
  doi: 10.1097/00003246-199206000-00025
– reference: 18807010 - Intensive Care Med. 2008 Dec;34(12):2134-5. doi: 10.1007/s00134-008-1275-5.
SSID ssj0017651
Score 2.1862924
Snippet Objective In sepsis, dysregulation of the immune response leads to rapid multiorgan failure and death. Accurate and timely diagnosis is lifesaving and should...
In sepsis, dysregulation of the immune response leads to rapid multiorgan failure and death. Accurate and timely diagnosis is lifesaving and should...
SourceID proquest
pubmed
pascalfrancis
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 2176
SubjectTerms Adult
Aged
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Anesthesiology
Biological and medical sciences
Biomarkers - blood
Case-Control Studies
Critical Care Medicine
Cytokines
Emergency and intensive care: infection, septic shock
Emergency Medicine
Extracellular matrix
Female
Hospitals
Humans
Intensive
Intensive care
Intensive care medicine
Intensive Care Units
Interleukin-6 - blood
Male
Medical sciences
Medicine
Medicine & Public Health
Middle Aged
Observational studies
Original
Osteopontin - blood
Pain Medicine
Pathogenesis
Pediatrics
Pneumology/Respiratory System
Prospective Studies
ROC Curve
Sepsis
Sepsis - blood
Sepsis - diagnosis
Systemic Inflammatory Response Syndrome - blood
Systemic Inflammatory Response Syndrome - diagnosis
Tumor necrosis factor-TNF
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1baxYxEB20gghFWm9dezEPPinB7C2bBaEUsVShPlgL39uSKxTa3bX5vv_vzN5KUfu2sJsQZpKZk53kHID3ikjEDO5OTGY9L7KQ8trnnmvMncKooG1OF5zPf8izy-L7qlxNZ3PidKxyjolDoHadpX_kn7JUYiZTqjjuf3MSjaLi6qSg8RieEHMZ7b2q1bLfSis5qC8SyR0vEGfPRU0xcIimecEHbtNMKl7cS0vbvY5ooTBKW_wLe_5VNx3S0ekOPJ9wJDsZHb8Lj3z7Ap6eT5Xyl_AZg8Dmhl3TmaDIusDoMkfXdyQMwfStZ1ct4cXoHT6xi28_L5huHYu-j1fxFVyefv315YxPSgncIsBY81SqqvJpEJYAnqlNbutcI7gqddBl7YUNTubGWe1M5RxaJqu0NhZtmnqrZf4attqu9XvAQqlVZQvsDndmSuhahdq4YEXppTSlSkDMhmrsRCNOahbXzUKAPNi2IXlLsm1TJPBhadKPHBoPfXx0z_pLi0yomn4DJrA_u6OZ1ltsltmRwLvlLS4Uqn7o1neb2MhaEbtclsCb0Yd3Y8EYVmGcS-Dj7NS7nv870LcPjmMfnmXj7OIiPYCt9e3GHyJ8WZujYZL-AT6n6T0
  priority: 102
  providerName: ProQuest
Title Serum levels of osteopontin are increased in SIRS and sepsis
URI https://link.springer.com/article/10.1007/s00134-008-1268-4
https://www.ncbi.nlm.nih.gov/pubmed/18807011
https://www.proquest.com/docview/216223884
https://www.proquest.com/docview/69814282
Volume 34
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1La9wwEB6aBEKhlPTtJtnqkFOKwJZtSYZetmXzKgklycL2ZCRZgkBqL9Hu_-_IrxCaFHKywZKQZ_T4RqP5BuBABhIxjdaJZsbSjLmEFja1VOHeGWvplElDgPP5BT-ZZ2eLfNHHcfvhtvvgkmxX6jHYLaCVjLZ0pIxLmm3AVo6mexjWczYdXQeCtzkXA7UdzRBdD67Mx5p4sBm9WiqPcnFdQovHEOc_3tJ2Ezragdc9eiTTTt1v4IWt38L2ee8ffwffcOqv_5DbcBPIk8aREMLRLJuQDoKoO0tu6oASva3wjVydXl4RVVfE26W_8e9hfjS7_nFC-_wI1CCsWNGESyFs4mITYJ0udGqKVCGkypVTeWFj4yqe6sqoSouqQskwoZQ2CWeJNYqnH2Czbmr7CYjLlRQmw-bQHpOxKqQrdOVMnFvOdS4jiAdBlaYnDw85LG7Lkfa4lW0ZkloG2ZZZBIdjlWXHnPG_wpMH0h9rsFgW4fAvgt1BHWU_y3zJ8E8Qckis_mX8itMj-DxUbZu1L3khA6cci-Bjp8P7vuDKJXB1i-DroNT7lp_s6Odnld6Fl6wbbTRO9mBzdbe2-whiVnoCG2IhJrA1Pf79c4bP77OLX5eTdij_BWs96jU
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrQRICPEmFFof4AKy6iSO40ggxKPVLu2uUB9Sb8F2bKlSSUKzK8SP4j8yzquqgN56i5TYsWbGM5899nwAL6UvIqZxdaIjYymPXEgzG1uqMHYyLZ0ysb_gPF-I6TH_cpKcrMHv4S6MP1Y5-MTWUReV8Xvk21EoMJJJyd_XP6gnjfLJ1YFBo7OKPfvrJ67Ymnezz6jeV1G0u3P0aUp7UgFqMBYvaShkmtrQMeOxkM50bLJYIQ5JlFNJZplxhYh1YVSh06II0VmkSmmDvw-tUSLGfm_AOo8RKUxg_ePO4uvBmLZIRcv36MvqUY7IfkijsrZqaRhz2lZTjYSk_FIgvFOrBnXiOjKNf6HdvzK1bQDcvQd3e-RKPnSmdh_WbPkAbs773PxDeItuZ_WdnPlTSA2pHPHXR6q68lQURJ1bclp6hNrYAp_I4ezgkKiyII2tm9PmERxfixgfw6SsSvsUiEuUTA3H7nAtKJnKpMt04QxLrBA6kQGwQVC56QuXe_6Ms3wsudzKNveEml62OQ_g9dik7qp2XPXx5iXpjy0iJjO_8RjAxqCOvJ_hTT7aYwBb41ucmj7fokpbrZpcZNLXs4sCeNLp8GIs6DVT9KwBvBmUetHzfwf67MpxbMGt6dF8P9-fLfY24HbUWRpl4XOYLM9X9gWCp6Xe7E2WwLfrniV_AGaRKRc
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1baxUxEB5qhSKIeHettnnQFyU0m71lQRGxHnqsLWItnLdtrlCou2tzDuJP89852Vspat_6trBJGOaeTDIfwAsRmogp3J0ori1NuYtpaRNLJcZOpoSTOgkPnA8O873j9NMiW6zB7_EtTLhWOfrEzlGbRocz8h0e5xjJhEh33HAr4svu7F37gwYAqVBoHdE0eg3Zt79-4u7Nv53voqhfcj77-O3DHh0ABqjGuLykcS6KwsaO6ZAXqVIlukwk5iSZdDIrLdPO5IkyWhpVGBOj4yikVBpJia2WeYLr3oCbRYJRE02pWEx7PRzaIT-GBns0xRx_LKiyrn9pnKS066vKc0HTSyHxdis9Ssf1sBr_ynv_qtl2oXB2F-4MOSx53yvdPViz9X3YOBiq9A_gDTqg1XdyFu4jedI4Eh6SNG0TQCmIPLfktA65qrcGv8jR_OsRkbUh3rb-1D-E42th4iNYr5vaPgHiMikKneJyuCsUTJbClco4zTKb5yoTEbCRUZUeWpgHJI2zamq-3PG2CtCagbdVGsGraUrb9--4avDWJe5PMzgTZTiCjGBzFEc12LqvJs2MYHv6i0YaKi-yts3KV3kpQmc7HsHjXoYXtKD_LNDHRvB6FOrFyv8l9OmVdGzDBtpG9Xl-uL8Jt3ivaJTFz2B9eb6yzzGLWqqtTl8JnFy3gfwBKygr5w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Serum+levels+of+osteopontin+are+increased+in+SIRS+and+sepsis&rft.jtitle=Intensive+care+medicine&rft.au=Vaschetto%2C+Rosanna&rft.au=Nicola%2C+Stefania&rft.au=Olivieri%2C+Carlo&rft.au=Boggio%2C+Elena&rft.date=2008-12-01&rft.issn=0342-4642&rft.volume=34&rft.issue=12&rft.spage=2176&rft_id=info:doi/10.1007%2Fs00134-008-1268-4&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0342-4642&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0342-4642&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0342-4642&client=summon